discovered that interleukin (IL)‐12, IL‐15 and IL‐18 induce memory‐like NK cells that exhibit augmented killing against AML, regardless of KIR‐ligand interactions, leading to an expanded NK cell pool of AML‐reactive effector cells. Here, IL15 is linked to acute myeloid leukemia.